Home
>
National Drug Code (NDC)
>
Gralise
Gralise - 13913-004-13 - (gabapentin)
Drug Information of Gralise
| Product NDC: | 13913-004 |
| Proprietary Name: | Gralise |
| Non Proprietary Name: | gabapentin |
| Active Ingredient(s): | 300 mg/1 & nbsp; gabapentin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gralise
| Product NDC: | 13913-004 |
| Labeler Name: | Depomed, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022544 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110128 |
Package Information of Gralise
| Package NDC: | 13913-004-13 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (13913-004-13) |
NDC Information of Gralise
| NDC Code | 13913-004-13 |
| Proprietary Name | Gralise |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (13913-004-13) |
| Product NDC | 13913-004 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | gabapentin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110128 |
| Marketing Category Name | NDA |
| Labeler Name | Depomed, Inc. |
| Substance Name | GABAPENTIN |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
